Tyrosine kinase activity of the EGF receptor is enhanced by the expression of oncogenic 70Z-Cbl

Oncogene
C B Thien, W Y Langdon

Abstract

The 120 kD product of the c-Cbl oncogene is a prominent substrate of protein tyrosine kinases that lacks a known catalytic activity but possesses an array of binding sites for cytoplasmic signalling proteins. An oncogenic form of Cbl was recently identified in the 70Z/3 pre-B cell lymphoma which has a small deletion at the N-terminus of the Ring finger domain. This form of Cbl, termed 70Z-Cbl, exhibits an enhanced level of tyrosine phosphorylation compared with c-Cbl. Here we demonstrate that the expression of 70Z-Cbl induces a tenfold enhancement in the kinase activity of the EGF receptor in serum-starved and EGF-stimulated cells. In serum-starved cells this results in EGF receptor autophosphorylation and the recruitment of Grb2, Shc and Sos1 but does not induce a corresponding increase in MAP kinase activity. Furthermore the expression of 70Z-Cbl greatly enhances EGF-induced tyrosine phosphorylation of the protein tyrosine phosphatase SHP-2. We also show that the Cbl/EGF receptor complex is predominantly associated with CrkII and is distinct to the Grb2/Shc/Sos1 complex that associates with the EGF receptor. These findings therefore demonstrate a biochemical effect of an oncogenic Cbl protein and support predictions from C. e...Continue Reading

Citations

Apr 21, 1999·Current Opinion in Cell Biology·P O HackelA Ullrich
Nov 3, 1998·Immunology and Cell Biology·C B Thien, W Y Langdon
Jun 8, 2010·The Journal of Biological Chemistry·Philip E RyanStanley Lipkowitz
May 27, 2010·Cancer Research·Stephen C KalesStanley Lipkowitz
Sep 8, 2009·Blood·Srinivasa Rao BandiUNKNOWN Study Alliance Leukemias
Jul 8, 1998·Proceedings of the National Academy of Sciences of the United States of America·S MiyakeH Band
Apr 8, 1998·Current Opinion in Genetics & Development·D Van VactorB G Neel
Feb 25, 2000·Molecular and Cellular Endocrinology·O GoupilleJ Djiane
Apr 7, 2009·Cellular Signalling·Michele JacobEllen Puré
Jun 8, 2007·European Journal of Cell Biology·Ivan Dikic, Mirko H H Schmidt
Feb 3, 2009·Traffic·Yaara Zwang, Yosef Yarden
Feb 1, 2005·Biochimica Et Biophysica Acta·Kazuya Machida, Bruce J Mayer
Oct 23, 2012·Biochimica Et Biophysica Acta·Bhopal MohapatraHamid Band
Jun 3, 2006·Journal of Cellular Physiology·Gayathri Swaminathan, Alexander Y Tsygankov
Mar 23, 1999·Oncogene·S A EttenbergS Lipkowitz
May 4, 2004·Nature Reviews. Cancer·Andreas GschwindAxel Ullrich
Apr 3, 2001·Nature Reviews. Molecular Cell Biology·C B Thien, W Y Langdon
Oct 19, 2001·Oncogene·A Y TsygankovG Swaminathan
Feb 4, 2006·Autoimmunity·Luiza GuilhermeMadeleine Cunningham
Jul 31, 1999·The Journal of Biological Chemistry·H WatermanY Yarden
Feb 13, 1999·The Journal of Biological Chemistry·Z ZhangY C Liu
Jul 13, 2001·The Journal of Biological Chemistry·M YokouchiR Baron
May 27, 2015·World Journal of Biological Chemistry·Yu-Wen Zhang

❮ Previous
Next ❯

Related Concepts

Related Feeds

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.